Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harald Herrmann

Showing results (191-200 of 237) with videos related to

Pageof 24
Sort By:
Acta Neuropathologica|March 5, 2025
Human brain tissue with MOGHE carrying somatic SLC35A2 variants reveal aberrant protein expression and protein loss in the white matterErica Cecchini, Simon Geffers, Roland Coras, et al.
Critical Reviews in Oncology/Hematology|February 27, 2010
Neoplastic stem cells: current concepts and clinical perspectivesAxel Schulenburg, Kira Brämswig, Harald Herrmann, et al.
The Journal of Biological Chemistry|November 26, 2011
Corneal antifibrotic switch identified in genetic and pharmacological deficiency of vimentinPaola Bargagna-Mohan, Riya R Paranthan, Adel Hamza, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 8, 2019
Oxygen and Conformation Dependent Protein Oxidation and Aggregation by Porphyrins in Hepatocytes and Light-Exposed CellsDhiman Maitra, Eric L Carter, Rani Richardson, et al.
Human Mutation|March 31, 2015
LMNA Mutation c.917T>G (p.L306R) Leads to Deleterious Hyper-Assembly of Lamin A/C and Associates with Severe Right Ventricular Cardiomyopathy and Premature AgingTero-Pekka Alastalo, Gun West, Song-Ping Li, et al.
Haematologica|January 19, 2011
Polo-like kinase-1 as a novel target in neoplastic mast cells: demonstration of growth-inhibitory effects of small interfering RNA and the Polo-like kinase-1 targeting drug BI 2536Barbara Peter, Karoline V Gleixner, Sabine Cerny-Reiterer, et al.
American Journal of Cancer Research|May 15, 2015
Prominin-1 (CD133, AC133) and dipeptidyl-peptidase IV (CD26) are indicators of infinitive growth in colon cancer cellsThomas W Grunt, Alexandra Hebar, Sylvia Laffer, et al.
Oncotarget|May 5, 2016
Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: patient-subgroups, prognostic impact, and technical aspectsMartin Culen, Marek Borsky, Veronika Nemethova, et al.
Human Molecular Genetics|December 20, 2002
Mutations at the mouse ichthyosis locus are within the lamin B receptor gene: a single gene model for human Pelger-Huët anomalyLeonard D Shultz, Bonnie L Lyons, Lisa M Burzenski, et al.
Plos One|February 3, 2012
The PI3-kinase/mTOR-targeting drug NVP-BEZ235 inhibits growth and IgE-dependent activation of human mast cells and basophilsKatharina Blatt, Harald Herrmann, Irina Mirkina, et al.
Pageof 24

Showing results (191-200 of 237) with videos related to

Sort By:
Pageof 24
Acta Neuropathologica|March 5, 2025
Human brain tissue with MOGHE carrying somatic SLC35A2 variants reveal aberrant protein expression and protein loss in the white matterErica Cecchini, Simon Geffers, Roland Coras, et al.
Critical Reviews in Oncology/Hematology|February 27, 2010
Neoplastic stem cells: current concepts and clinical perspectivesAxel Schulenburg, Kira Brämswig, Harald Herrmann, et al.
The Journal of Biological Chemistry|November 26, 2011
Corneal antifibrotic switch identified in genetic and pharmacological deficiency of vimentinPaola Bargagna-Mohan, Riya R Paranthan, Adel Hamza, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 8, 2019
Oxygen and Conformation Dependent Protein Oxidation and Aggregation by Porphyrins in Hepatocytes and Light-Exposed CellsDhiman Maitra, Eric L Carter, Rani Richardson, et al.
Human Mutation|March 31, 2015
LMNA Mutation c.917T>G (p.L306R) Leads to Deleterious Hyper-Assembly of Lamin A/C and Associates with Severe Right Ventricular Cardiomyopathy and Premature AgingTero-Pekka Alastalo, Gun West, Song-Ping Li, et al.
Haematologica|January 19, 2011
Polo-like kinase-1 as a novel target in neoplastic mast cells: demonstration of growth-inhibitory effects of small interfering RNA and the Polo-like kinase-1 targeting drug BI 2536Barbara Peter, Karoline V Gleixner, Sabine Cerny-Reiterer, et al.
American Journal of Cancer Research|May 15, 2015
Prominin-1 (CD133, AC133) and dipeptidyl-peptidase IV (CD26) are indicators of infinitive growth in colon cancer cellsThomas W Grunt, Alexandra Hebar, Sylvia Laffer, et al.
Oncotarget|May 5, 2016
Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: patient-subgroups, prognostic impact, and technical aspectsMartin Culen, Marek Borsky, Veronika Nemethova, et al.
Human Molecular Genetics|December 20, 2002
Mutations at the mouse ichthyosis locus are within the lamin B receptor gene: a single gene model for human Pelger-Huët anomalyLeonard D Shultz, Bonnie L Lyons, Lisa M Burzenski, et al.
Plos One|February 3, 2012
The PI3-kinase/mTOR-targeting drug NVP-BEZ235 inhibits growth and IgE-dependent activation of human mast cells and basophilsKatharina Blatt, Harald Herrmann, Irina Mirkina, et al.
Pageof 24